Bio-Path Holdings, Inc. (BPTH)
USD 0.15
(0.0%)
USD 0.15
(0.0%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | -178 Thousand USD | 0.0% |
| 2022 | -178 Thousand USD | -10.56% |
| 2021 | -161 Thousand USD | -6.62% |
| 2020 | -151 Thousand USD | 34.35% |
| 2019 | -230 Thousand USD | 46.01% |
| 2018 | -426 Thousand USD | -1251.35% |
| 2017 | 37 Thousand USD | 184.62% |
| 2016 | 13 Thousand USD | 106.44% |
| 2015 | -201.76 Thousand USD | 0.0% |
| 2014 | - USD | 0.0% |
| 2013 | - USD | 0.0% |
| 2012 | - USD | 0.0% |
| 2011 | - USD | 0.0% |
| 2010 | - USD | 0.0% |
| 2009 | - USD | 0.0% |
| 2008 | - USD | 100.0% |
| 2007 | -1669.00 USD | -127.61% |
| 2006 | 6045.00 USD | -61.19% |
| 2005 | 15.57 Thousand USD | -34.82% |
| 2004 | 23.89 Thousand USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | -32 Thousand USD | 31.91% |
| 2024 Q1 | -47 Thousand USD | -120.17% |
| 2023 Q2 | -46 Thousand USD | -2.22% |
| 2023 Q4 | 233 Thousand USD | 606.52% |
| 2023 Q3 | -46 Thousand USD | 0.0% |
| 2023 Q1 | -45 Thousand USD | 2.17% |
| 2023 FY | -178 Thousand USD | 0.0% |
| 2022 Q1 | -45 Thousand USD | -7.14% |
| 2022 Q3 | -44 Thousand USD | -2.33% |
| 2022 Q2 | -43 Thousand USD | 4.44% |
| 2022 FY | -178 Thousand USD | -10.56% |
| 2022 Q4 | -46 Thousand USD | -4.55% |
| 2021 Q3 | - USD | 0.0% |
| 2021 FY | -161 Thousand USD | -6.62% |
| 2021 Q1 | -38 Thousand USD | 0.0% |
| 2021 Q2 | - USD | 100.0% |
| 2021 Q4 | -42 Thousand USD | 0.0% |
| 2020 Q2 | - USD | 0.0% |
| 2020 FY | -151 Thousand USD | 34.35% |
| 2020 Q1 | - USD | 0.0% |
| 2020 Q4 | - USD | 0.0% |
| 2020 Q3 | - USD | 0.0% |
| 2019 Q4 | - USD | 0.0% |
| 2019 Q2 | - USD | 0.0% |
| 2019 Q3 | - USD | 0.0% |
| 2019 FY | -230 Thousand USD | 46.01% |
| 2019 Q1 | - USD | 0.0% |
| 2018 Q3 | - USD | 0.0% |
| 2018 FY | -426 Thousand USD | -1251.35% |
| 2018 Q4 | - USD | 0.0% |
| 2018 Q2 | - USD | 0.0% |
| 2018 Q1 | - USD | -100.0% |
| 2017 Q2 | - USD | 0.0% |
| 2017 Q4 | 37 Thousand USD | 0.0% |
| 2017 FY | 37 Thousand USD | 184.62% |
| 2017 Q1 | - USD | -100.0% |
| 2017 Q3 | - USD | 0.0% |
| 2016 FY | 13 Thousand USD | 106.44% |
| 2016 Q1 | - USD | 0.0% |
| 2016 Q2 | - USD | 0.0% |
| 2016 Q3 | - USD | 0.0% |
| 2016 Q4 | 13 Thousand USD | 0.0% |
| 2015 Q3 | - USD | 0.0% |
| 2015 Q1 | - USD | 0.0% |
| 2015 FY | -201.76 Thousand USD | 0.0% |
| 2015 Q2 | - USD | 0.0% |
| 2015 Q4 | - USD | 0.0% |
| 2014 Q3 | - USD | 0.0% |
| 2014 Q1 | - USD | 0.0% |
| 2014 Q2 | - USD | 0.0% |
| 2014 FY | - USD | 0.0% |
| 2014 Q4 | - USD | 0.0% |
| 2013 Q3 | - USD | 0.0% |
| 2013 FY | - USD | 0.0% |
| 2013 Q4 | - USD | 0.0% |
| 2013 Q2 | - USD | 0.0% |
| 2013 Q1 | - USD | 0.0% |
| 2012 FY | - USD | 0.0% |
| 2012 Q2 | - USD | 0.0% |
| 2012 Q1 | - USD | 0.0% |
| 2012 Q4 | - USD | 0.0% |
| 2012 Q3 | - USD | 0.0% |
| 2011 FY | - USD | 0.0% |
| 2011 Q4 | - USD | 0.0% |
| 2011 Q3 | - USD | 0.0% |
| 2011 Q1 | - USD | 0.0% |
| 2011 Q2 | - USD | 0.0% |
| 2010 Q1 | - USD | 0.0% |
| 2010 Q3 | - USD | 0.0% |
| 2010 Q4 | - USD | 0.0% |
| 2010 FY | - USD | 0.0% |
| 2010 Q2 | - USD | 0.0% |
| 2009 Q3 | - USD | 0.0% |
| 2009 FY | - USD | 0.0% |
| 2009 Q4 | - USD | 0.0% |
| 2009 Q2 | - USD | 0.0% |
| 2009 Q1 | - USD | 0.0% |
| 2008 Q4 | - USD | 0.0% |
| 2008 Q2 | - USD | 0.0% |
| 2008 FY | - USD | 100.0% |
| 2008 Q3 | - USD | 0.0% |
| 2008 Q1 | - USD | 0.0% |
| 2007 Q4 | - USD | 0.0% |
| 2007 FY | -1669.00 USD | -127.61% |
| 2007 Q1 | 4571.00 USD | 804.31% |
| 2007 Q2 | -27.83 Thousand USD | -708.86% |
| 2007 Q3 | - USD | 100.0% |
| 2006 Q1 | 1145.00 USD | 196.79% |
| 2006 Q4 | -649.00 USD | 36.37% |
| 2006 Q3 | -1020.00 USD | -133.53% |
| 2006 Q2 | 3042.00 USD | 165.68% |
| 2006 FY | 6045.00 USD | -61.19% |
| 2005 Q2 | 4683.00 USD | 29.94% |
| 2005 Q3 | 3041.00 USD | -35.06% |
| 2005 FY | 15.57 Thousand USD | -34.82% |
| 2005 Q4 | -1183.00 USD | -138.9% |
| 2005 Q1 | 3604.00 USD | 242.91% |
| 2004 Q3 | 6238.00 USD | 0.0% |
| 2004 FY | 23.89 Thousand USD | 0.0% |
| 2004 Q4 | 1051.00 USD | -83.15% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| America Great Health | 168.58 Thousand USD | 205.583% |
| Ampio Pharmaceuticals, Inc. | -250 Thousand USD | 28.8% |
| Aridis Pharmaceuticals, Inc. | - USD | Infinity% |
| Biora Therapeutics, Inc. | -551 Thousand USD | 67.695% |
| Better Therapeutics, Inc. | -2.72 Million USD | 93.477% |
| Calithera Biosciences, Inc. | -1.38 Million USD | 87.148% |
| Comera Life Sciences Holdings, Inc. | 422.71 Thousand USD | 142.109% |
| Gene Biotherapeutics, Inc. | - USD | Infinity% |
| eFFECTOR Therapeutics, Inc. | -22.91 Million USD | 99.223% |
| Eloxx Pharmaceuticals, Inc. | - USD | Infinity% |
| Evelo Biosciences, Inc. | - USD | Infinity% |
| Evolutionary Genomics, Inc. | -1.02 Million USD | 82.575% |
| Finch Therapeutics Group, Inc. | -7.09 Million USD | 97.49% |
| Galera Therapeutics, Inc. | -259 Thousand USD | 31.274% |
| Innovation1 Biotech Inc. | -52.69 Thousand USD | -237.774% |
| Kiromic BioPharma, Inc. | -2.79 Million USD | 93.634% |
| Molecular Templates, Inc. | 50.39 Million USD | 100.353% |
| Navidea Biopharmaceuticals, Inc. | -119.29 Thousand USD | -49.21% |
| NexImmune, Inc. | -1.02 Million USD | 82.634% |
| Orgenesis Inc. | -5.72 Million USD | 96.891% |
| Panbela Therapeutics, Inc. | -25.64 Million USD | 99.306% |
| Point of Care Nano-Technology, Inc. | -4601.00 USD | -3768.724% |
| PaxMedica, Inc. Common Stock | - USD | Infinity% |
| Scopus BioPharma Inc. | - USD | Infinity% |
| Sorrento Therapeutics, Inc. | 29.38 Million USD | 100.606% |
| Statera Biopharma, Inc. | -488.31 Thousand USD | 63.548% |
| TRACON Pharmaceuticals, Inc. | -232 Thousand USD | 23.276% |
| Trevena, Inc. | 1.45 Million USD | 112.234% |
| Vaxxinity, Inc. | -2.23 Million USD | 92.032% |
| Vaccinex, Inc. | -16 Million USD | 98.888% |
| Vicapsys Life Sciences, Inc. | - USD | Infinity% |
| Viracta Therapeutics, Inc. | -492 Thousand USD | 63.821% |
| ZIVO Bioscience, Inc. | 11.61 Thousand USD | 1633.161% |